Study compares GLP-1 drug benefits and finds substantial variation in clinical effects
A new umbrella review reveals how GLP-1 therapies shape cardiovascular, renal, and metabolic outcomes in type 2 diabetes…
Understanding leptin’s dual function in MAFLD pathogenesis
Metabolic dysfunction-associated fatty liver disease (MAFLD) has emerged as a predominant chronic liver condition globally, intricately linked with…
The caffeine conundrum in rapid depression treatments
Perhaps the most intriguing implication of recent breakthrough research lies in an unexpected connection: the most rigorous mechanistic…
Researchers achieve long-term remission with novel T cell therapies for HPV-related cancers
Researchers from Rutgers Cancer Institute, New Jersey’s only National Cancer Institute (NCI) – designated Comprehensive Cancer Center, and…
Single daily polypill improves heart function and quality of life in heart failure patients
Adults with heart failure with reduced ejection fraction (HFrEF) who took a “polypill” combining medications prescribed for the…
New NIH grants fuel research in oral cancer treatment and pain relief
Researchers at the School of Dentistry at UT Health San Antonio, the academic health center of The University…
Opioid receptors caught in motion offering clues for safer painkillers
Scientists have known for decades that opioids relieve pain by binding to molecular switches in the brain called…
Scientists uncover new obesity genes that reshape understanding of weight and disease risk
A global research team maps how rare and common gene variants jointly drive obesity and metabolic disease, offering…
Diabetes remission possible with GLP-1 drugs, Italian study confirms
Real-world data from over 14,000 Italian adults reveal that GLP-1 receptor agonists can induce remission in type 2…
Research opens new avenues for treating asthma and other inflammatory diseases
For decades, scientists have thought they understood the biochemical machinery that causes asthma-inflammation in the lungs that constricts…
New study offers hope for patients with treatment-resistant focal epilepsy
About one-third of patients with focal epilepsy, a common form of the neurological disorder, are believed to respond…
New personalized therapy boosts tamoxifen effectiveness in breast cancer patients
Breast cancer is the most common cancer among women worldwide (WHO, 2023). The Dr. Margarete Fischer-Bosch Institute of…